SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009078
Filing Date
2017-05-05
Accepted
2017-05-05 16:03:57
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q flxn-10q_20170331.htm 10-Q 1066698
2 EX-10.1 flxn-ex101_10.htm EX-10.1 24287
3 EX-10.2 flxn-ex102_293.htm EX-10.2 12344
4 EX-31.1 flxn-ex311_6.htm EX-31.1 10057
5 EX-32.1 flxn-ex321_360.htm EX-32.1 6684
  Complete submission text file 0001564590-17-009078.txt   4346196

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT flxn-20170331.xml EX-101.INS 918217
7 XBRL TAXONOMY EXTENSION SCHEMA flxn-20170331.xsd EX-101.SCH 37651
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE flxn-20170331_cal.xml EX-101.CAL 45270
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flxn-20170331_def.xml EX-101.DEF 73002
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20170331_lab.xml EX-101.LAB 270394
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20170331_pre.xml EX-101.PRE 206073
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36287 | Film No.: 17818347
SIC: 2834 Pharmaceutical Preparations